This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 May 22;370(21):2049.

doi: 10.1056/NEJMc1403303.

Bevacizumab for newly diagnosed glioblastoma

Olivier L Chinot, Wolfgang Wick, Timothy Cloughesy

PMID: 24860870
DOI: 10.1056/NEJMc1403303

Comment

Bevacizumab for newly diagnosed glioblastoma

Olivier L Chinot et al. N Engl J Med. 2014.

. 2014 May 22;370(21):2049.

doi: 10.1056/NEJMc1403303.

Authors

Olivier L Chinot, Wolfgang Wick, Timothy Cloughesy

PMID: 24860870
DOI: 10.1056/NEJMc1403303

No abstract available

PubMed Disclaimer

Comment on

Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.
Chinot OL, Wick W, Mason W, Henriksson R, Saran F, Nishikawa R, Carpentier AF, Hoang-Xuan K, Kavan P, Cernea D, Brandes AA, Hilton M, Abrey L, Cloughesy T. Chinot OL, et al. N Engl J Med. 2014 Feb 20;370(8):709-22. doi: 10.1056/NEJMoa1308345. N Engl J Med. 2014. PMID: 24552318 Clinical Trial.
Bevacizumab for newly diagnosed glioblastoma.
Haines IE, Gabor Miklos GL. Haines IE, et al. N Engl J Med. 2014 May 22;370(21):2048. doi: 10.1056/NEJMc1403303. N Engl J Med. 2014. PMID: 24849089 No abstract available.

Similar articles

Bevacizumab for newly diagnosed glioblastoma.
Haines IE, Gabor Miklos GL. Haines IE, et al. N Engl J Med. 2014 May 22;370(21):2048. doi: 10.1056/NEJMc1403303. N Engl J Med. 2014. PMID: 24849089 No abstract available.
Bevacizumab in glioblastoma--still much to learn.
Fine HA. Fine HA. N Engl J Med. 2014 Feb 20;370(8):764-5. doi: 10.1056/NEJMe1313309. N Engl J Med. 2014. PMID: 24552324 No abstract available.
Neuro-oncology: Bevacizumab prolongs progression-free survival but not overall survival in newly diagnosed glioblastoma.
Malkki H. Malkki H. Nat Rev Neurol. 2014 Apr;10(4):179. doi: 10.1038/nrneurol.2014.47. Epub 2014 Mar 18. Nat Rev Neurol. 2014. PMID: 24638136 No abstract available.
Bevacizumab and glioblastoma: scientific review, newly reported updates, and ongoing controversies.
Field KM, Jordan JT, Wen PY, Rosenthal MA, Reardon DA. Field KM, et al. Cancer. 2015 Apr 1;121(7):997-1007. doi: 10.1002/cncr.28935. Epub 2014 Sep 26. Cancer. 2015. PMID: 25263092 Review.
Bevacizumab and other targeted agents in the upfront treatment of glioblastoma.
Clarke JL. Clarke JL. Semin Radiat Oncol. 2014 Oct;24(4):273-8. doi: 10.1016/j.semradonc.2014.06.002. Semin Radiat Oncol. 2014. PMID: 25219812 Review.

See all similar articles

Cited by

Immunotherapy Associated Neurotoxicity in Pediatric Oncology.
Shalabi H, Nellan A, Shah NN, Gust J. Shalabi H, et al. Front Oncol. 2022 Feb 21;12:836452. doi: 10.3389/fonc.2022.836452. eCollection 2022. Front Oncol. 2022. PMID: 35265526 Free PMC article. Review.
A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma.
Lopez J, Lai-Kwon J, Molife R, Welsh L, Tunariu N, Roda D, Fernández-García P, Lladó V, McNicholl AG, Rosselló CA, Taylor RJ, Azaro A, Rodón J, Sludden J, Veal GJ, Plummer R, Urruticoechea A, Lahuerta A, Mujika K, Escribá PV. Lopez J, et al. Br J Cancer. 2023 Sep;129(5):811-818. doi: 10.1038/s41416-023-02356-1. Epub 2023 Jul 24. Br J Cancer. 2023. PMID: 37488446 Free PMC article. Clinical Trial.
Molecularly Targeted Drugs Plus Radiotherapy and Temozolomide Treatment for Newly Diagnosed Glioblastoma: A Meta-Analysis and Systematic Review.
Su J, Cai M, Li W, Hou B, He H, Ling C, Huang T, Liu H, Guo Y. Su J, et al. Oncol Res. 2016;24(2):117-28. doi: 10.3727/096504016X14612603423511. Oncol Res. 2016. PMID: 27296952 Free PMC article.
Re-irradiation alternatives for recurrent high-grade glioma.
Dong Y, Fu C, Guan H, Zhang T, Zhang Z, Zhou T, Li B. Dong Y, et al. Oncol Lett. 2016 Oct;12(4):2261-2270. doi: 10.3892/ol.2016.4926. Epub 2016 Aug 1. Oncol Lett. 2016. PMID: 27703519 Free PMC article.
Molecular and Circulating Biomarkers in Patients with Glioblastoma.
Senhaji N, Squalli Houssaini A, Lamrabet S, Louati S, Bennis S. Senhaji N, et al. Int J Mol Sci. 2022 Jul 5;23(13):7474. doi: 10.3390/ijms23137474. Int J Mol Sci. 2022. PMID: 35806478 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information